Your browser doesn't support javascript.
loading
Advances in high-density lipoprotein physiology: surprises, overturns, and promises.
Constantinou, Caterina; Karavia, Eleni A; Xepapadaki, Eva; Petropoulou, Peristera-Ioanna; Papakosta, Eugenia; Karavyraki, Marilena; Zvintzou, Evangelia; Theodoropoulos, Vassilis; Filou, Serafoula; Hatziri, Aikaterini; Kalogeropoulou, Christina; Panayiotakopoulos, George; Kypreos, Kyriakos E.
Afiliação
  • Constantinou C; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Karavia EA; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Xepapadaki E; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Petropoulou PI; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Papakosta E; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Karavyraki M; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Zvintzou E; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Theodoropoulos V; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Filou S; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Hatziri A; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Kalogeropoulou C; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Panayiotakopoulos G; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece.
  • Kypreos KE; Pharmacology Department, University of Patras Medical School, Rio Achaias, Greece kkypreos@med.upatras.gr.
Am J Physiol Endocrinol Metab ; 310(1): E1-E14, 2016 Jan 01.
Article em En | MEDLINE | ID: mdl-26530157
ABSTRACT
Emerging evidence strongly supports that changes in the HDL metabolic pathway, which result in changes in HDL proteome and function, appear to have a causative impact on a number of metabolic disorders. Here, we provide a critical review of the most recent and novel findings correlating HDL properties and functionality with various pathophysiological processes and disease states, such as obesity, type 2 diabetes mellitus, nonalcoholic fatty liver disease, inflammation and sepsis, bone and obstructive pulmonary diseases, and brain disorders.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipoproteínas HDL / Doenças Metabólicas Limite: Humans Idioma: En Revista: Am J Physiol Endocrinol Metab Assunto da revista: ENDOCRINOLOGIA / FISIOLOGIA / METABOLISMO Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipoproteínas HDL / Doenças Metabólicas Limite: Humans Idioma: En Revista: Am J Physiol Endocrinol Metab Assunto da revista: ENDOCRINOLOGIA / FISIOLOGIA / METABOLISMO Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Grécia